Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

New vasopressin antagonist from JT with aquaretic effects in animals

April 1, 1998

Detrol approved by FDA for overactive bladder

March 30, 1998

Synaptic licenses technology for BPH treatment to Glaxo Wellcome

March 25, 1998

Genetic basis for congenital kidney disease pinpointed by BioStratum scientists

March 23, 1998

Taiwan researchers identify lead potassium channel opener selective for bladder

March 18, 1998

Use of aspirin to prevent preeclampsia should be discontinued, NIH researchers say

March 13, 1998

Detrusitol launched in U.K. and Germany

March 11, 1998

New potassium channel activators from American Home

March 11, 1998

Testosterone 5alpha-reductase inhibitors disclosed by Sumitomo Metal

March 10, 1998

Benefits of finasteride in patients with benign prostatic hyperplasia

March 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...